期刊文献+

冠心病患者治疗前后促红细胞生成素和血液流变学的动态变化及对血黏度的影响 被引量:19

Dynamic changes of erythropoietin and hemorheology in patients with CHD before and after treatment and effect on blood viscosity
下载PDF
导出
摘要 目的观察促红细胞生成素(EPO)、血常规、血液流变学参数在冠心病患者PCI前后24 h的动态变化及对血黏度的影响。方法选择冠心病患者117例,分为急性心肌梗死组(心梗组)45例,不稳定性心绞痛组(不稳定组)50例,稳定性心绞痛组(稳定组)22例;另选取健康体检者40例为对照组。对患者入院、PCI后24 h的EPO、血常规和血液流变学进行对比分析,并进行Pearson相关分析。结果与治疗前比较,心梗组、不稳定组、稳定组患者治疗后FPO、红细胞聚集指数、红细胞压积明显下降,血红蛋白、血小板、全血黏度低切明显升高(P<0.05,P<0.01);Pearson相关分析显示,冠心病患者治疗前和治疗后EPO与红细胞聚集指数、红细胞压积呈正相关,与血红蛋白、全血黏度低切、血小板呈负相关(P<0.05,P<0.01)。结论内源性EPO可能通过红细胞聚集指数、红细胞压积、血红蛋白、血小板、全血黏度低切间接影响冠心病患者的血黏度,且治疗前和治疗后冠心病患者均处于高血黏度状态。 Objective To observe the dynamic changes of erythropoietin(EPO),blood routine and hemorheology parameters in patients with coronary heart disease before and 24 hours after percu taneous coronary intervention(PCI) and effect on blood viscosity. Methods 117 patients with coronary heart disease were divided into 3 groups:acute myocardial infarction(MI), unstable angina (UA) and stable angina(SA),40 healthy subjects served as control group. EPO, blood routine and hemorheology were measured on admission and 24 hours after PCI. Comparative analysis and Pearson correlation analysis were done. Results After treatment,EPO,index of erythrocyte aggregation and hematocrit decreased, hemoglobin, platelet count and low-shearing whole blood vis cosity increased significantly in MI,UA and SA groups compared with before treatment. Pearson correlation analysis showed that EPO was correlated significantly positively with index of eryth rocyte aggregation and hematocrit ( P〈 0.05 ), negatively with haemoglobin, platelet count, low-shearing whole blood viscosity before and 24 hours after intervention in patiens with coronary heart disease(P〈0.05). Conclusions Endogenous EPO might influence blood viscosity through index of erythrocyte aggregation, hematoerit, haemoglobin, platelet,low-shearing whole blood vis- cosity indirectly,and patients with coronary heart disease were in status of high blood viscosity before and 24 hours after treatment.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2011年第10期870-873,共4页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
基金 兰州大学医学科研基金(LZUYX200724)
关键词 冠心病 红细胞生成素 血细胞 血液流变学 血液黏度 coronary disease erythropoietin blood cells hemorheology blood viscosity
  • 相关文献

参考文献16

  • 1Brydon L, Magid K, Steptoe A. Platelets, coronary heart disease, and stress. Brain Behav Immunol, 2006,20 : 113-119.
  • 2Vaya A,Simo M, Santaolaria M, et al. Plasma viscosity and related cardiovascular risk factors in a Spanish Mediterranean population. Thromb Res, 2007,120 :489-495.
  • 3Makarova NA, Zakharov |UM. On erythropoietin level formation in the blood under conditions of acute disturbance of car diac function. Ross Fiziol Zh Im I M Sechenova,2009,95:961 -968.
  • 4Krause K, Fehse B,Jaquet K, et al. Analysis of progenitor cell mobilization and erythropoietin plasma levels in patients with acute myocardial infarction. Exp Clin Cardiol, 2005,10: 104- 107.
  • 5Nakamura R,Takahashi A, Yamada T, et al. Erythropoietin in patients with acute coronary syndrome and its cardioprotective action after percutaneous coronary intervention. Circ J,2009,73:1920 -1926.
  • 6Alioglu E, Ercan E, Sonmez- Tamer G, et al. Decreased circulatory erythropoietin in hyperacute phase of myocardial ischemia. Int J Cardiol,2011,146:e49-e52.
  • 7Ferrario M, Massa M,Rosti V, et al. Early haemoglobin-independent increase of plasma erythropoietin levels in patients with acute myocardial infarction. Eur Heart J, 2007,28: 1805 -1813.
  • 8吕东苗,孙玉玺,沈琪琳.冠心病患者血清促红细胞生成素与血液流变学及血细胞参数的关系[J].中国临床康复,2004,8(3):448-449. 被引量:5
  • 9张春秀,黄晏,张锦.急性心肌梗死患者血清促红细胞生成素变化及其临床意义[J].山东医药,2009,49(44):102-103. 被引量:4
  • 10Irace C,Scavelli F,Carallo C,et al. Plasma and blood viscosity in metabolic syndrome. Nutr Metab Cardiovasc Dis,2009,19: 476-480.

二级参考文献8

  • 1Tan CC, Eckardt KU, Firth JD, et al. Feedback modlation of renal and hepatic erythropoietin mRNA in response to graded anemia and hypoxia [J]. Am J Physiol, 1992,263(3 Pt 2) :F474-481.
  • 2Wu H, Lee SH, Gao J, et al. Inactivation of erythropoietin leads to defects in cardiac morphogenesis [ J ]. Development, 1999,26 (6) : 3597 -3605.
  • 3Parsa C J, Matsumoto A, Kim J, et al. A novel protective effect of erythropoietin in the infarcted heart [J]. Clin Invest, 2003,112 (7) :999-1007.
  • 4Rafiee P, Shi Y, Su J, et al. Erythropoietin protects the infant heart against isehemia-reperfusion injury by triggering multiple signaling pathways [ J ]. Basic Res Cardiol, 2005, 100 (3) : 187-197.
  • 5Miki T, Miura T, Yano T, et al. Alteration in erythropoietin-induced cardioprotective signaling by postinfarct ventricular remodeling [J]. J Pharmacol Exp Ther, 2006,317( 1 ) :68-75.
  • 6Namiuchi S, Kagaya Y, Ohta J, et al. High serum erythropaietin level is associated with smaller infarct size in patients with acute myocardial infarction who undergo successful primary percutaneous coronary intervention [J], J Am Coll Cardiol, 2005,45(9) :1406-1412.
  • 7刘奇志,吴军,朱宁,魏刘东,曲鹏,李淑媛.高血压及冠心病患者血浆脂肪酸组成与含量[J].中国临床康复,2003,7(15):2158-2159. 被引量:22
  • 8徐方芳,沙勇,马瑞琴,张金莉.平板运动试验与冠状动脉造影对冠心病危险分层的意义[J].中国临床康复,2003,7(15):2176-2177. 被引量:10

共引文献7

同被引文献214

引证文献19

二级引证文献158

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部